Skip to main content
SpringerLink
Log in

Guillain-Barré Syndrome and Myasthenia Gravis

  • Chapter
Book cover Care of the Critically Ill Patient

  • 924 Accesses

Abstract

Patients with neurological disease usually require intensive care for three main reasons. These are coma, muscle paralysis and respiratory failure. Guillain-Barré syndrome and myasthenia gravis are examples of neurological diseases which can give rise to acute respiratory failure. They are both autoimmune diseases and reflect the changing face of neurology, neurological prognosis and treatment in the light of the advances in molecular biology.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Adams SL, Mathews J, Grammer LC (1984) Drugs that can exacerbate myasthenia gravis. Ann Emerg Med 13: 532–538

    Article  PubMed  CAS  Google Scholar 

  2. Appenzeller O, Marshall J (1963) Vasomotor disturbance in Landry-Guillain-Barré Syndrome. Arch Neurol 9: 368–372

    Article  PubMed  CAS  Google Scholar 

  3. Arnason BGW (1975) In: Dyck PJ, Thomas PK, Lambert EH (eds) Peripheral neuropathy. Saunders, Philadelphia, p 1110

    Google Scholar 

  4. Asbury AK, Arnason BGW, Karp HR, McFarlin DE (1978) Criteria for the diagnosis of Guillain-Barré syndrome. Ann Neurol 3: 565–566

    Article  Google Scholar 

  5. Azar I (1984) The response of patients with neuromuscular disorders to muscle relaxants: a review. Anesthesiology 61: 173–187

    Article  PubMed  CAS  Google Scholar 

  6. Brown JC, Charlton JE (1975) A study of sensitivity to curare in myasthenic disorders using a regional technique. J Neurol Neurosurg Psychiat 38: 27–33

    Article  PubMed  CAS  Google Scholar 

  7. Buckingham JM, Howard FM, Bernatz PE et al. (1976) The value of thymectomy in myasthenia gravis. Ann Surg 184: 453–458

    Article  PubMed  CAS  Google Scholar 

  8. Castleman B (1966) The pathology of the thymus gland in myasthenia gravis. Ann NY Acad Sci 135: 496–503

    Article  PubMed  CAS  Google Scholar 

  9. Compston DAS, Vincent A, Newsom-Davis J, Batchelor JR (1980) Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis. Brain 103: 579–601

    Google Scholar 

  10. Cook SD, Dowling PC, Murray MR, Whitaker JN (1971) Circulating demyelinating factors in acute idiopathic polyneuropathy. Arch Neurol 24: 136–144

    Article  PubMed  CAS  Google Scholar 

  11. Dau PC, Denys EH (1982) Plasmapheresis and immuno-suppressive drug therapy in the Eaton-Lambert syndrome. Ann Neurol 11: 570–575

    Article  PubMed  CAS  Google Scholar 

  12. Dowling PC, Menonna JP, Cook SD (1977) Cytomegalovirus complement fixation antibody in Guillain-Barré syndrome. Neurology 27: 1153

    PubMed  CAS  Google Scholar 

  13. Drachman DB, Adams RN, Stanley EF, Pestronk A (1980) Mechanisms of acetylcholine receptor loss in myasthenia gravis. J Neurol Neurosurg Psychiat 43: 601–610

    Article  PubMed  CAS  Google Scholar 

  14. Dreyer F (1982) Acetylcholine receptor. Br J Anaesth 54: 115–130

    Article  PubMed  CAS  Google Scholar 

  15. Eaton LM, Lambert EH (1957) Electromyography and electric stimulation of nerves in diseases of motor units: observations on the myasthenic syndrome associated with malignant tumours. JAMA 163: 1117–1124

    Article  CAS  Google Scholar 

  16. Engel AG (1984) Myasthenia gravis and myasthenic syndromes. Ann Neurol 16: 519–534

    Article  PubMed  CAS  Google Scholar 

  17. Feasby TE, Hahn AF, Gilbert JJ (1980) Passive transfer of demyelinating activity in Guillain-Barré polyneuropathy. Neurology 30: 363

    Google Scholar 

  18. Ferguson RJ, Wright DJ, Willey RF, Crompton GK, Grant IWB (1981) Suxamethonium is dangerous in polyneuropathy. Br Med J 282: 298–299

    Article  Google Scholar 

  19. Fukuoka T, Engel AG, Lang B, Newsom-Davis J, Prior C, Wray DW (1987) Lambert-Eaton myasthenic syndrome: 1. Early morphological effects of IgG on the presynaptic membrane active zones. Ann Neurol 22: 193–199

    Google Scholar 

  20. Guillain-Barré Syndrome Study Group (1985) Plasmapheresis and acute Guillain-Barré Syndrome. Neurology 35: 104–109

    Google Scholar 

  21. Hertel G, Mertens HG, Reuther P, Ricker K (1979) The treatment of myasthenia gravis with azathioprine. In: Dau PC (ed) Plasmapheresis and the immunobiology of myasthenia gravis. Houghton Mifflin, Boston, p 315

    Google Scholar 

  22. Hughes RA (1978) Acute inflammatory polyneuropathy. Br J Hosp Med 20: 688–693

    PubMed  CAS  Google Scholar 

  23. Hughes RA, Newsom-Davis J, Perkin GD, Pierce JM (1978) Controlled trial prednisolone in acute polyneuropathy. Lancet ii: 750–753

    Article  Google Scholar 

  24. International Multicentre Trial (1975) Prevention of fatal post-operative pulmonary embolism by low doses of heparin. Lancet ii: 45–51

    Google Scholar 

  25. Kim YI, Neher E (1988) IgG from patients with Lambert- Eaton syndrome blocks voltage-dependent calcium channels. Science 239: 405–408

    Article  PubMed  CAS  Google Scholar 

  26. Kistler J, Stroud RM, Klymkowsky MW et al. (1982) Structure and function of an acetylcholine receptor. Biophys J 37: 371–383

    Article  PubMed  CAS  Google Scholar 

  27. Lang B, Newsom-Davis J, Wray D, Vincent A, Murray N (1981) Autoimmune aetiology for myasthenic (Eaton- Lambert) syndrome. Lancet ii: 224–226

    Article  Google Scholar 

  28. Leese J (1976) Thrombotic complication in acute polyneuritis. Br Med J 1: 585

    Article  PubMed  CAS  Google Scholar 

  29. Lesser RP, Hauser WA, Kurland LT, Mulder DW (1973) Epidemiological features of the Guillain-Barré syndrome. Neurology 23: 1269–1272

    PubMed  CAS  Google Scholar 

  30. Lichtenfeld P (1971) Autonomic dysfunction in the Guillain-Barré syndrome. Am J Med 50: 772–780

    Article  PubMed  CAS  Google Scholar 

  31. Lindstrom JM, Lennin VA, Seybold ME, Whittingham S (1976) Experimental autoimmune myasthenia gravis and myasthenia gravis: biochemical and immunochemical aspects. Ann NY Acad Sei 274: 254–274

    Article  CAS  Google Scholar 

  32. Lindstrom J, Tzartos S, Gullick W et al. (1983) Use of monoclonal antibodies to study acetylcholine receptors from electric organs, muscle, and brain and the autoimmune response to receptor in myasthenia gravis. Cold Spring Harbor Symp Quant Biol 48 Pt 1: 89–99

    Google Scholar 

  33. Löffel NB, Rossi LN, Mumenthaler M, Lütschg J, Ludin H-P (1977) The Landry-Guillain-Barré Syndrome: complications, prognosis and natural history in 123 cases. J Neurol Sci 33: 71–79

    Article  PubMed  Google Scholar 

  34. Loh L, Goldman M, Newsom-Davis J (1977) The assessment of diaphragm function. Medicine (Baltimore) 56: 165–169

    Article  CAS  Google Scholar 

  35. Mann JD, Johns TR, Campa JF (1976) Long-term administration of corticosteroids in myasthenia gravis. Neurology 26: 729–740

    PubMed  CAS  Google Scholar 

  36. Mishima M, Takai T, Imoto K, Noda M, Takahashi T, Numa S (1986) Molecular destruction between fetal and adult forms of muscle acetylcholine receptor. Nature 321: 406–411

    Article  Google Scholar 

  37. Moore B, Safani M, Keesey J (1988) Possible exacerbation of myasthenia gravis by ciprofloxacin. Lancet i: 882

    Google Scholar 

  38. Morel E, Eymard B, Vernet-der-Garabedian B, Pannier C, Dulac O, Bach JF (1988) Neonatal myasthenia gravis, a new clinical and immunological appraisal on 30 cases. Neurology 38: 138–142

    PubMed  CAS  Google Scholar 

  39. Newsom-Davis J, Pinching AJ, Vincent A, Wilson SG (1978) Function of circulating antibody to acetylcholine receptor in myasthenia gravis investigated by plasma exchange. Neurology 28: 266–272

    PubMed  CAS  Google Scholar 

  40. Newsom-Davis J, Vincent A, Wilson SG, Ward CD (1979) Long-term effects of repeated plasma exchange in myasthenia gravis. Lancet i: 464–468

    Google Scholar 

  41. Osserman KE, Genkins G (1971) Studies in myasthenia gravis: review of a twenty-year experience in over 1200 patients. Mt Sinai J Med 38: 497–537

    PubMed  CAS  Google Scholar 

  42. Penn AS, Schotland DL, Rowland LP (1971) Immunology of muscle disease. Ass Res Nerv Dis Proc 49: 215–240

    CAS  Google Scholar 

  43. Ropper AH, Shahani BT (1984) Pain in Guillain-Barré Syndrome. Arch Neurol 41: 511–514

    Article  PubMed  CAS  Google Scholar 

  44. Rosenfeld B, Borel C, Hanley D (1986) Epidural morphine treatment of pain in Guillain-Barré Syndrome. Arch Neurol 43: 1194–1196

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. L. Loh
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of London, London WC1, UK

    Jack Tinker BSc, FRCP, FRCS, DIC (Dean of Postgraduate Medicine, Honorary Consultant Physician) (Dean of Postgraduate Medicine, Honorary Consultant Physician)

  2. The Middlesex Hospital, London W1, UK

    Jack Tinker BSc, FRCP, FRCS, DIC (Dean of Postgraduate Medicine, Honorary Consultant Physician) (Dean of Postgraduate Medicine, Honorary Consultant Physician)

  3. Harvard Medical School and Massachusetts General Hospital, 02114, Boston, Massachusetts, USA

    Warren M. Zapol MD (Professor of Anaesthesia) (Professor of Anaesthesia)

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer-Verlag London Limited

About this chapter

Cite this chapter

Loh, L. (1992). Guillain-Barré Syndrome and Myasthenia Gravis. In: Tinker, J., Zapol, W.M. (eds) Care of the Critically Ill Patient. Springer, London. https://doi.org/10.1007/978-1-4471-3400-8_59

Download citation

  • DOI: https://doi.org/10.1007/978-1-4471-3400-8_59

  • Publisher Name: Springer, London

  • Print ISBN: 978-1-4471-3402-2

  • Online ISBN: 978-1-4471-3400-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation